References
- Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br. J. Psychiatry 114(512), 797–811 (1968).
- Sperling RA, Aisen PS, Beckett LA et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers. Dement. 7(3), 280–292 (2011).
- Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56(3), 303–308 (1999).
- Petersen RC, Morris JC. Mild cognitive impairment as a clinical entity and treatment target. Arch. Neurol. 62(7), 1160–1163 (2005).
- Plassman BL, Langa KM, Fisher GG et al. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology 29(1–2), 125–132 (2007).
- Galeone F, Pappalardo S, Chieffi S, Iavarone A, Carlomagno S. Anosognosia for memory deficit in amnestic mild cognitive impairment and Alzheimer’s disease. Int. J. Geriatr. Psychiatry 26(7), 695–701 (2011).
- Galvin JE, Roe CM, Powlishta KK et al. The AD8: a brief informant interview to detect dementia. Neurology 65(4), 559–564 (2005).
- Jorm AF. The Informant Questionnaire on cognitive decline in the elderly (IQCODE): a review. Int. Psychogeriatr. 16(3), 275–293 (2004).
- Malek-Ahmadi M, Davis K, Belden C et al. Validation and diagnostic accuracy of the Alzheimer’s questionnaire. Age Ageing 41(3), 396–399 (2012).
- Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43(11), 2412–2414 (1993).
- Morris JC, Storandt M, Miller JP et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch. Neurol. 58(3), 397–405 (2001).
- Isella V, Villa L, Russo A, Regazzoni R, Ferrarese C, Appollonio IM. Discriminative and predictive power of an informant report in mild cognitive impairment. J. Neurol. Neurosurg. Psychiatr. 77(2), 166–171 (2006).
- Sikkes SA, van den Berg MT, Knol DL et al. How useful is the IQCODE for discriminating between Alzheimer’s disease, mild cognitive impairment and subjective memory complaints? Dement. Geriatr. Cogn. Disord. 30(5), 411–416 (2010).
- Sabbagh MN, Malek-Ahmadi M, Kataria R et al. The Alzheimer’s questionnaire: a proof of concept study for a new informant-based dementia assessment. J. Alzheimers Dis. 22(3), 1015–1021 (2010).
- Malek-Ahmadi M, Davis K, Belden CM, Jacobson S, Sabbagh MN. Informant-reported cognitive symptoms that predict amnestic mild cognitive impairment. BMCGeriatr. 12, 3 (2012).
- Galvin JE, Fagan AM, Holtzman DM, Mintun MA, Morris JC. Relationship of dementia screening tests with biomarkers of Alzheimer’s disease. Brain 133(11), 3290–3300 (2010).
Website
- Affordable Care Act Expands Medicare Coverage for Prevention and Wellness (online). www.medicareadvocacy.org/2010/09/affordable-care-act-expands-medicare-coverage-for-prevention-and-wellness (Accessed 18 August 2011)